长效生长抑素类似物兰瑞肽成功治疗晚期肝细胞癌
Successful treatment of an advanced hepatocellular carcinoma with the long-acting somatostatin analog lanreotide.
作者信息
Raderer M, Hejna M H, Kurtaran A, Kornek G V, Valencak J B, Oberhuber G, Vorbeck F, Virgolini I, Scheithauer W
机构信息
Department of Internal Medicine I, University of Vienna, Austria.
出版信息
Am J Gastroenterol. 1999 Jan;94(1):278-9. doi: 10.1111/j.1572-0241.1999.00821.x.
Treatment options for hepatocellular cancer apart from surgical resection are limited because of the drug-refractory nature of this disease. Little is known about the role of somatostatin-receptors in hepatocellular cancer, and somatostatin analogs have not been investigated for treatment of this malignancy. We present the case of a 68-yr-old male, who was successfully treated with the long-acting somatostatin analog lanreotide.
除手术切除外，肝细胞癌的治疗选择有限，因为这种疾病具有药物难治性。关于生长抑素受体在肝细胞癌中的作用知之甚少，而且尚未对生长抑素类似物治疗这种恶性肿瘤进行研究。我们报告一例68岁男性患者，他接受长效生长抑素类似物兰瑞肽治疗成功。
Zotero 插件